About the Authors

Linda J. Bristow

Linda.bristow@bms.com

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Amy E. Easton

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Yu-Wen Li

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Digavalli V. Sivarao

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Regina Lidge

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Kelli M. Jones

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Debra Post-Munson

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Christopher Daly

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Nicholas J. Lodge

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Lizbeth Gallagher

Affiliation Lead Discovery and Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Thaddeus Molski

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Richard Pieschl

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Ping Chen

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Adam Hendricson

Affiliation Lead Discovery and Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Ryan Westphal

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

James Cook

Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Christiana Iwuagwu

Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Daniel Morgan

Affiliation Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Yulia Benitex

Affiliation Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Dalton King

Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

John E. Macor

Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Robert Zaczek

Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Richard Olson

Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

Competing Interests

All authors were paid employees of Bristol-Myers Squibb Company at the time this research was conducted. In addition many authors own Bristol-Myers Squibb Company stock and some are inventors on patents relating to BMS-933043, the agent described in this manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: LJB AEE Y-WL DVS NJL RW DM DK JEM RZ RO. Performed the experiments: RL KMJ DP-M CD LG TM RP PC AH JC CI YB. Analyzed the data: AAEE Y-WL DVS RL KMJ DP-M CD NJL LG TM RP PC AH RW DM YB. Contributed reagents/materials/analysis tools: JC CI DK. Wrote the paper: LJB.